Spitalul Municipal Ploiesti

The clinical trial program is centered on neoplasms, with a strong focus on improving care for people living with lung cancer, breast cancer, and other advanced solid tumors. Studies at this hospital are exploring new treatment options, comparing them with current standards, and looking for better ways to extend survival and control disease progression.

• Trials in non-small cell lung cancer and small cell lung cancer are evaluating new immunotherapy and targeted approaches for advanced or recurrent disease.
• Research in breast cancer, including triple-negative breast cancer, is testing novel therapies aimed at improving response and disease control.
• Studies in gastrointestinal cancers such as colorectal cancer, gastric cancer, and pancreatic cancer are assessing new combinations to strengthen treatment effectiveness.
• Additional work includes prostate cancer, head and neck cancer, melanoma, and cholangiocarcinoma, with a broad emphasis on advancing oncology care.

Across the site’s 23 trials, investigators are mainly focused on testing innovative therapies, comparing them with existing options, and improving outcomes for patients with difficult-to-treat cancers. The research activity reflects a broad and active oncology portfolio within Spitalul Municipal Ploiesti.